Last update 21 Nov 2024

HLA-A02 restricted HIG2

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication-
Inactive Indication
Advanced Renal Cell Carcinoma
Originator Organization
Iwate Medical UniversityIwate Medical University
Active Organization-
Inactive Organization
Iwate Medical UniversityIwate Medical University
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HLA-A02 restricted HIG2
NCT01254838 / CompletedPhase 1IIT
Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma
100 Clinical Results associated with HLA-A02 restricted HIG2
Login to view more data
100 Translational Medicine associated with HLA-A02 restricted HIG2
Login to view more data
100 Patents (Medical) associated with HLA-A02 restricted HIG2
Login to view more data
100 Deals associated with HLA-A02 restricted HIG2
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Renal Cell CarcinomaPhase 1-
Iwate Medical UniversityIwate Medical University
01 Nov 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free